Skip to content
HomeLatest newsJohnson & Johnson takes a top spot on the 2017 Thomson Reuters Diversity & Inclusion Index
A photo of a woman leading a meeting

Johnson & Johnson takes a top spot on the 2017 Thomson Reuters Diversity & Inclusion Index

The company came in at #2 on the list of the 100 most diverse and inclusive workplaces around the world.

Johnson & Johnson has secured the #2 ranking on the 2017 Thomson Reuters Diversity & Inclusion Index.

The index selects the top 100 publicly traded companies out of a pool of more than 6,000, based on performance across such categories as diversity, inclusion and people development.

Johnson & Johnson’s positioning—up two spots from last year—reinforces its long commitment to creating a “culture of belonging” among its more than 130,000 employees worldwide, according to Chief Diversity & Inclusion Officer Wanda Bryant Hope.

“Johnson & Johnson is proud to be recognized as #2 on the Thomson Reuters Diversity & Inclusion Index,” she says. “We know the best way to reach the patients, doctors and consumers we serve—whose demographics are rapidly changing—is by having a workforce that reflects their diversity. The commitment we have to inclusion is a key element in further enabling our people to be themselves, deliver their best and change the world.”


Why a Diverse Workforce Is a Priority for Us

Johnson & Johnson prides itself on its diversity & inclusion initiatives, which helped us top the Thomson Reuters list.

More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.